These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11958993)

  • 21. Development of small molecules that mimic the binding of omega-conotoxins at the N-type voltage-gated calcium channel.
    Schroeder CI; Smythe ML; Lewis RJ
    Mol Divers; 2004; 8(2):127-34. PubMed ID: 15209164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.
    Wen L; Yang S; Qiao H; Liu Z; Zhou W; Zhang Y; Huang P
    Br J Pharmacol; 2005 Jul; 145(6):728-39. PubMed ID: 15880145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactive Mimetics of Conotoxins and other Venom Peptides.
    Duggan PJ; Tuck KL
    Toxins (Basel); 2015 Oct; 7(10):4175-98. PubMed ID: 26501323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of Z-butylidenephthalide on presynaptic N-type Ca²⁺ channels in isolated guinea-pig ileum.
    Chen M; Ko WC
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):159-66. PubMed ID: 26497186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress of study on the structure and function of omega-conotoxins].
    Chen XY; Zhan JB
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):85-8. PubMed ID: 14966950
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons.
    Morris JL; Ozols DI; Lewis RJ; Gibbins IL; Jobling P
    Br J Pharmacol; 2004 Mar; 141(6):961-70. PubMed ID: 14993106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels.
    Motin L; Yasuda T; Schroeder CI; Lewis RJ; Adams DJ
    Eur J Neurosci; 2007 Jan; 25(2):435-44. PubMed ID: 17284184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisympathetic and hemodynamic property of a dual L/N-type Ca(2+) channel blocker cilnidipine in rats.
    Takahara A; Koganei H; Takeda T; Iwata S
    Eur J Pharmacol; 2002 Jan; 434(1-2):43-7. PubMed ID: 11755164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent updates of N-type calcium channel blockers with therapeutic potential for neuropathic pain and stroke.
    Yamamoto T; Takahara A
    Curr Top Med Chem; 2009; 9(4):377-95. PubMed ID: 19442208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of effects of T and N type calcium channel blockers on the electroencephalogram recordings in Wistar Albino Glaxo/Rij rats, an absence epilepsy model.
    Durmus N; Gültürk S; Kaya T; Demir T; Parlak M; Altun A
    Indian J Pharmacol; 2015; 47(1):34-8. PubMed ID: 25821308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rank-order inhibition by omega-conotoxins in human and animal autonomic nerve preparations.
    Sanger GJ; Ellis ES; Harries MH; Tilford NS; Wardle KA; Benham CD
    Eur J Pharmacol; 2000 Jan; 388(1):89-95. PubMed ID: 10657551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum.
    Dobrev D; Ravens U
    Eur J Pharmacol; 2003 Feb; 461(2-3):105-11. PubMed ID: 12586205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.
    Ku IW; Cho S; Doddareddy MR; Jang MS; Keum G; Lee JH; Chung BY; Kim Y; Rhim H; Kang SB
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5244-8. PubMed ID: 16876404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological and biophysical characterization of voltage-gated calcium currents in the endopiriform nucleus of the guinea pig.
    Brevi S; de Curtis M; Magistretti J
    J Neurophysiol; 2001 May; 85(5):2076-87. PubMed ID: 11353024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
    Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channels.
    Sairaman A; Cardoso FC; Bispat A; Lewis RJ; Duggan PJ; Tuck KL
    Bioorg Med Chem; 2018 Jul; 26(11):3046-3059. PubMed ID: 29622412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional expression of L-, N-, P/Q-, and R-type calcium channels in the human NT2-N cell line.
    Neelands TR; King AP; Macdonald RL
    J Neurophysiol; 2000 Dec; 84(6):2933-44. PubMed ID: 11110822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
    Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2014 May; 24(9):2053-6. PubMed ID: 24726802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional solution structure of omega-conotoxin TxVII, an L-type calcium channel blocker.
    Kobayashi K; Sasaki T; Sato K; Kohno T
    Biochemistry; 2000 Dec; 39(48):14761-7. PubMed ID: 11101291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.